- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Bone mineral testing device gains approval
Alara of Hayward, CA, has received 510(k) clearance from the FDA to market Alara MetriScan, a tabletop device that allows physicians to perform in-office bone and mineral density testing on patients at risk for osteoporosis and related bone
Alara of Hayward, CA, has received 510(k) clearance from the FDA to market Alara MetriScan, a tabletop device that allows physicians to perform in-office bone and mineral density testing on patients at risk for osteoporosis and related bone fracture.
The device scans a patients phalanges to estimate bone mineral density, which can be a predictor of osteoporosis and hip fracture risk.
The Alara MetriScan is a digital radiographic imaging device that uses storage phosphor technology to replace x-ray film as a radiation detector. Total radiation exposure to the patient is less than 5% of a typical dental x-ray, the firm says.
Alara is a privately held medical technology company that designs, manufactures, and markets medical imaging products based on storage phosphor technology.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).
